Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • michael-steffen
    Member
    • Dec 2012
    • 18

    #1

    Going from orthologous groups to Pfam domain and descriptions

    I am trying to go from orthologous groups generated deduced from OrthoMCL, to Pfam domain identifiers and descriptions. While I can sorta do this in OrthoMCL, the output makes it very difficult go link to orthogroups at a large scale. An example of the output(copied and pasted from excel looks like this:

    Name: OG5_130999

    Table: Pfam Domains
    [Accession Number] [Symbol] [Description] [Count] [domain_index]
    PF00041 fn3 Fibronectin type III domain 548 41
    PF00047 ig Immunoglobulin domain 18 47
    PF00102 Y_phosphatase Protein-tyrosine phosphatase 1 98
    PF00147 Fibrinogen_C Fibrinogen beta and gamma chains, C-terminal globular domain 1 142


    Does anyone know a better way to ID pfam accession numbers and descriptions from orthogroup numbers? Alternatively, can anyone tell me how I can get the file in excel to have the OG5 number next to all the rows?

    Thanks,
    Mike

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    10-30-2026, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
72 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...